New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 7, 2014
06:41 EDTAKERAkers Biosciences signs distribution agreement for infectious disease tests
Akers Biosciences announces a distribution agreement with Thirty Six Strategies General Trading, for the sale of the Company's PIFA PLUSS Infectious Disease Rapid Assay product line and Tri-Cholesterol "Check". The three year exclusive agreement is subject to performance minimum purchase requirements. 36S is permitted to market the Company's products in Australia, Singapore, the United Arab Emirates and Oman. Under the terms of the distribution agreement 36S is expected to immediately begin marketing the company's tests to a large and varied customer base including hospitals, paramedic and emergency services, non-governmental organizations and military forces. 36S will focus on distribution of the company's rapid HIV, Hepatitis B, Malaria and Dengue Fever tests; as well as its rapid cholesterol test, Tri-Cholesterol "Check".
News For AKER From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 6, 2015
07:11 EDTAKERAkers Biosciences commercializes BreathScan OxiChek, BreathScan KetoChek
Subscribe for More Information
September 30, 2015
07:05 EDTAKERAkers Biosciences signs distribution deals in India, Germany, Italy, Scandinavia
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use